Lifestyle modification and risk factor control in the prevention and treatment of atrial fibrillation
Arch Cardiol Mex. 2024 Feb 21. doi: 10.24875/ACM.22000236. Online ahead of print.ABSTRACTAtrial fibrillation (AF) is the most prevalent arrhythmia and is related with significant morbidity, mortality and costs. In spite of relevant advances in the prevention of embolic events and rhythm control, little has been done to reduce its prevalence, progression and impact, since it increases with ageing as well as with common risk factors such as alcohol intake, tobacco use and stress as well as with arterial hypertension, diabetes mellitus, heart failure, sleep apnea, kidney failure, chronic pulmonary obstructive disease, ischemi...
Source: Archivos de Cardiologia de Mexico - February 21, 2024 Category: Cardiology Authors: Humberto Rodr íguez-Reyes Enrique Asensio-Lafuente Jorge E Coss ío-Aranda Gabriela Borrayo-S ánchez Marco Alcocer-Gamba Ana Berni-Betancourd Eva M Picos-Bovio Carlos F Gallegos-De Luna C ésar I Laguna-Muñoz V íctor A Corona-Martínez Luz M Mu ñoz-G Source Type: research
Lifestyle modification and risk factor control in the prevention and treatment of atrial fibrillation
Arch Cardiol Mex. 2024 Feb 21. doi: 10.24875/ACM.22000236. Online ahead of print.ABSTRACTAtrial fibrillation (AF) is the most prevalent arrhythmia and is related with significant morbidity, mortality and costs. In spite of relevant advances in the prevention of embolic events and rhythm control, little has been done to reduce its prevalence, progression and impact, since it increases with ageing as well as with common risk factors such as alcohol intake, tobacco use and stress as well as with arterial hypertension, diabetes mellitus, heart failure, sleep apnea, kidney failure, chronic pulmonary obstructive disease, ischemi...
Source: Archivos de Cardiologia de Mexico - February 21, 2024 Category: Cardiology Authors: Humberto Rodr íguez-Reyes Enrique Asensio-Lafuente Jorge E Coss ío-Aranda Gabriela Borrayo-S ánchez Marco Alcocer-Gamba Ana Berni-Betancourd Eva M Picos-Bovio Carlos F Gallegos-De Luna C ésar I Laguna-Muñoz V íctor A Corona-Martínez Luz M Mu ñoz-G Source Type: research
Lifestyle modification and risk factor control in the prevention and treatment of atrial fibrillation
Arch Cardiol Mex. 2024 Feb 21. doi: 10.24875/ACM.22000236. Online ahead of print.ABSTRACTAtrial fibrillation (AF) is the most prevalent arrhythmia and is related with significant morbidity, mortality and costs. In spite of relevant advances in the prevention of embolic events and rhythm control, little has been done to reduce its prevalence, progression and impact, since it increases with ageing as well as with common risk factors such as alcohol intake, tobacco use and stress as well as with arterial hypertension, diabetes mellitus, heart failure, sleep apnea, kidney failure, chronic pulmonary obstructive disease, ischemi...
Source: Archivos de Cardiologia de Mexico - February 21, 2024 Category: Cardiology Authors: Humberto Rodr íguez-Reyes Enrique Asensio-Lafuente Jorge E Coss ío-Aranda Gabriela Borrayo-S ánchez Marco Alcocer-Gamba Ana Berni-Betancourd Eva M Picos-Bovio Carlos F Gallegos-De Luna C ésar I Laguna-Muñoz V íctor A Corona-Martínez Luz M Mu ñoz-G Source Type: research
Lifestyle modification and risk factor control in the prevention and treatment of atrial fibrillation
Arch Cardiol Mex. 2024 Feb 21. doi: 10.24875/ACM.22000236. Online ahead of print.ABSTRACTAtrial fibrillation (AF) is the most prevalent arrhythmia and is related with significant morbidity, mortality and costs. In spite of relevant advances in the prevention of embolic events and rhythm control, little has been done to reduce its prevalence, progression and impact, since it increases with ageing as well as with common risk factors such as alcohol intake, tobacco use and stress as well as with arterial hypertension, diabetes mellitus, heart failure, sleep apnea, kidney failure, chronic pulmonary obstructive disease, ischemi...
Source: Archivos de Cardiologia de Mexico - February 21, 2024 Category: Cardiology Authors: Humberto Rodr íguez-Reyes Enrique Asensio-Lafuente Jorge E Coss ío-Aranda Gabriela Borrayo-S ánchez Marco Alcocer-Gamba Ana Berni-Betancourd Eva M Picos-Bovio Carlos F Gallegos-De Luna C ésar I Laguna-Muñoz V íctor A Corona-Martínez Luz M Mu ñoz-G Source Type: research
Influence of sexual hormones on Chagas disease
CONCLUSIONS: Our results showed that testosterone increased infection severity, whereas estradiol had the opposite effect. This research improves the understanding of sex hormones´infuence upon this infection to contribute with the handling of Chagas´disease.PMID:38377617 | DOI:10.24875/ACM.23000018 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - February 20, 2024 Category: Cardiology Authors: Oscar A Reboreda-Hernandez Rocio Ortiz-Butron Benjamin Nogueda-Torres Nayeli Gonzalez-Rodriguez Source Type: research
Tratamiento endovascular exitoso de aneurisma del ventr ículo izquierdo en un paciente pediátrico
CONCLUSIONS: Endovascular management of ventricular diverticula, using alternative materials to those commonly used, is an attractive option with satisfactory results in these patients.PMID:38377958 | DOI:10.24875/ACM.23000112 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - February 20, 2024 Category: Cardiology Authors: Isabel C S ánchez-Escobar Silvia J Galvis-Blanco Luis H D íaz-Medina Rafael Correa-Vel ásquez Rafael Lince-Varela Source Type: research
Influence of sexual hormones on Chagas disease
CONCLUSIONS: Our results showed that testosterone increased infection severity, whereas estradiol had the opposite effect. This research improves the understanding of sex hormones´infuence upon this infection to contribute with the handling of Chagas´disease.PMID:38377617 | DOI:10.24875/ACM.23000018 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - February 20, 2024 Category: Cardiology Authors: Oscar A Reboreda-Hernandez Rocio Ortiz-Butron Benjamin Nogueda-Torres Nayeli Gonzalez-Rodriguez Source Type: research
Translational research: from the laboratory bench to the patient's bedside. Congenital heart disease: a window to knowledge
Arch Cardiol Mex. 2024 Feb 15. doi: 10.24875/ACM.23000125. Online ahead of print.NO ABSTRACTPMID:38359402 | DOI:10.24875/ACM.23000125 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - February 15, 2024 Category: Cardiology Authors: Juan Calder ón-Colmenero Diego B Ortega-Zhind ón Nonanzit P érez-Hernández Jos é M Rodríguez-Pérez Jorge L Cervantes-Salazar Source Type: research
Closure of patent ductus arteriosus with Occlutech < sup > TM < /sup > device, experience in an andean country
CONCLUSIONS: OcclutechTM Duct Occluder device was effective and safe for the closure of patent ductus arteriosus type E, A and D in low-altitude and high-altitude dwellers, whether they were children or adults, even when these ductus arteriosus were hypertensive.PMID:38359430 | DOI:10.24875/ACM.23000126 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - February 15, 2024 Category: Cardiology Authors: Ra úl E Ríos-Méndez Mar ía E Araúz-Martínez Jorge A Oliveros-Rivero Yeiber J Crespo-Guti érrez Yesenia W P érez-Vite Source Type: research
Circulatory support with venovenous ECMO in a patient with reperfusion pulmonary edema after pulmonary artery thromboendarterectomy
We present the case of a 60-year-old woman with a history of acute pulmonary embolism due to deep vein thrombosis of the right pelvic limb who was diagnosed later with CTEPH who was admitted for scheduled surgical treatment involving bilateral PTE. However, during the immediate postoperative period, she developed cardiogenic shock and refractory hypoxemia secondary to pulmonary reperfusion syndrome following the surgical procedure. As a result, she required veno-venous ECMO circulatory support for 6 days, leading to resolution of the pulmonary condition and clinical improvement.PMID:38359441 | DOI:10.24875/ACM.23000142 (So...
Source: Archivos de Cardiologia de Mexico - February 15, 2024 Category: Cardiology Authors: Emmanuel A Lazcano-D íaz Uriel Encarnaci ón-Martínez Cristhian J Gayt án-García Daniel Manzur-Sandoval Francisco J Gonz ález-Ruiz Edgar Garc ía-Cruz Ángel Ramos-Enríquez Luis E Santos-Mart ínez Luis A Cota-Apodaca Benjam ín I Hernández-Mejía Source Type: research
Interventional treatment in an adult: postductal aortic coarctation, aortic stenosis and persistence of the ductus arteriosum
Arch Cardiol Mex. 2024 Feb 15. doi: 10.24875/ACM.23000174. Online ahead of print.NO ABSTRACTPMID:38359448 | DOI:10.24875/ACM.23000174 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - February 15, 2024 Category: Cardiology Authors: Werner Schlie-Villa Gerson Mar ín-Rendón Ximena Ayala-Huerta Juan S Carrillo-Calzontzi Flor T Rosas-Arag ón Source Type: research
The current state of renal sympathetic denervation in hypertension
Arch Cardiol Mex. 2024 Feb 15. doi: 10.24875/ACM.23000191. Online ahead of print.ABSTRACTThis review provides an overview of the efficacy and safety of renal sympathetic denervation as a therapeutic approach for resistant hypertension. While the initial enthusiasm was sparked by the results of early clinical trials, it was dampened by the findings of the Symplicity HTN-3 study. However, recent advances in catheter technology and more refined patient selection criteria have yielded more promising results. Subsequent studies, such as SPYRAL HTN-OFF MED and RADIANCE II, demonstrated significant reductions in blood pressure, e...
Source: Archivos de Cardiologia de Mexico - February 15, 2024 Category: Cardiology Authors: Jaime A G ómez-Rosero Laura Duque-Gonz ález Juan M Senior-S ánchez Source Type: research
Letter to the editor regarding "Prevalence of arterial hypertension in hospitalized pediatric patients"
Arch Cardiol Mex. 2024 Feb 15. doi: 10.24875/ACM.23000233. Online ahead of print.NO ABSTRACTPMID:38359469 | DOI:10.24875/ACM.23000233 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - February 15, 2024 Category: Cardiology Authors: Marilyn A Almora-Orellana Jannipsa Espinoza-Guevara Source Type: research
Translational research: from the laboratory bench to the patient's bedside. Congenital heart disease: a window to knowledge
Arch Cardiol Mex. 2024 Feb 15. doi: 10.24875/ACM.23000125. Online ahead of print.NO ABSTRACTPMID:38359402 | DOI:10.24875/ACM.23000125 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - February 15, 2024 Category: Cardiology Authors: Juan Calder ón-Colmenero Diego B Ortega-Zhind ón Nonanzit P érez-Hernández Jos é M Rodríguez-Pérez Jorge L Cervantes-Salazar Source Type: research
Closure of patent ductus arteriosus with Occlutech < sup > TM < /sup > device, experience in an andean country
CONCLUSIONS: OcclutechTM Duct Occluder device was effective and safe for the closure of patent ductus arteriosus type E, A and D in low-altitude and high-altitude dwellers, whether they were children or adults, even when these ductus arteriosus were hypertensive.PMID:38359430 | DOI:10.24875/ACM.23000126 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - February 15, 2024 Category: Cardiology Authors: Ra úl E Ríos-Méndez Mar ía E Araúz-Martínez Jorge A Oliveros-Rivero Yeiber J Crespo-Guti érrez Yesenia W P érez-Vite Source Type: research
